Primary Open Angle Glaucoma Clinical Trial
— PAIROfficial title:
The PAIR Study. Positive Airway Pressure and Intraocular Relationship: IOP Response to a Short-term Application of CPAP
Verified date | June 2018 |
Source | Papworth Hospital NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Lowering of the pressure in the eye (intraocular pressure, IOP) is the only proven treatment
for Primary Open-angle Glaucoma (POAG). However, even effective reduction of IOP by
pharmacological or surgical means does not always change the course of the disease or prevent
the onset of glaucoma. Some people with POAG also suffer from Obstructive Sleep Apnoea (OSA),
an increasingly common sleep disorder which is known to affect heart and blood vessels, and
may contribute to glaucoma progression. OSA is treated with Continuous Positive Airway
Pressure (CPAP); however using this type of breathing support may raise IOP.
This study aims to establish whether a short-term application of CPAP in awake subjects leads
to an increase in IOP. Patients with treated POAG, patients with newly diagnosed untreated
POAG and control subjects without glaucoma will be included. CPAP will be applied at several
different pressure levels for a total of 2 hours during which IOP and ocular perfusion
pressure (OPP) will be measured. If CPAP is shown to raise IOP or alter OPP it could be
necessary to assess available alternative treatment options for OSA.
Status | Terminated |
Enrollment | 46 |
Est. completion date | January 5, 2018 |
Est. primary completion date | January 5, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years and older |
Eligibility |
Inclusion Criteria: - Age >40 years - Able to give informed consent and attend for the study visit. Exclusion Criteria: - Previous surgical treatment for glaucoma - Current or recent (within 4 weeks) CPAP or non-invasive ventilation (NIV) use - History of face mask intolerance - Any facial lesion preventing safe CPAP mask application - Allergy to silicone - Any contraindications to rebound tonometry, including: corneal scarring, microphthalmos, buphthalmos, nystagmus, keratoconus, abnormal central corneal thickness, corneal ectasia, active corneal infection, , and corneal dystrophies. - Concomitant eye diseases known to affect IOP, including: treated wet age related macular degeneration (ARMD), central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), uveitis and diabetic retinopathy. - Significant lung disease (including previous pneumothorax, previous or current respiratory failure, severe Chronic Obstructive Pulmonary Disease (COPD), bullous lung disease, difficult to control asthma, acute chest infection) - Significant heart disease (including heart failure, unstable arrhythmias, pulmonary hypertension) - Untreated upper gastro-intestinal obstruction - Acute infectious diseases - Known or suspected pregnancy |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Hinchingbrooke Hospital NHS Foundation Trust | Huntingdon | Cambridgeshire |
Lead Sponsor | Collaborator |
---|---|
Papworth Hospital NHS Foundation Trust | Hinchingbrooke Hospital NHS Trust |
United Kingdom,
Becker H, Grote L, Ploch T, Schneider H, Stammnitz A, Peter JH, Podszus T. Intrathoracic pressure changes and cardiovascular effects induced by nCPAP and nBiPAP in sleep apnoea patients. J Sleep Res. 1995 Jun;4(S1):125-129. — View Citation
Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of glaucoma in patients with obstructive sleep apnoea--a cross-sectional case-series. Eye (Lond). 2008 Sep;22(9):1105-9. Epub 2007 May 4. — View Citation
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct;120(10):1268-79. — View Citation
Kiekens S, Veva De Groot, Coeckelbergh T, Tassignon MJ, van de Heyning P, Wilfried De Backer, Verbraecken J. Continuous positive airway pressure therapy is associated with an increase in intraocular pressure in obstructive sleep apnea. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):934-40. doi: 10.1167/iovs.06-1418. — View Citation
Kohler M. Deleterious systemic effects of OSA: how much evidence do we need? Thorax. 2015 Sep;70(9):817-8. doi: 10.1136/thoraxjnl-2015-207247. Epub 2015 Jul 14. — View Citation
Mojon DS, Hess CW, Goldblum D, Fleischhauer J, Koerner F, Bassetti C, Mathis J. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology. 1999 May;106(5):1009-12. — View Citation
Pépin JL, Chiquet C, Tamisier R, Lévy P, Almanjoumi A, Romanet JP. Frequent loss of nyctohemeral rhythm of intraocular pressure restored by nCPAP treatment in patients with severe apnea. Arch Ophthalmol. 2010 Oct;128(10):1257-63. doi: 10.1001/archophthalmol.2010.220. — View Citation
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013 May 1;177(9):1006-14. doi: 10.1093/aje/kws342. Epub 2013 Apr 14. — View Citation
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intraocular pressure (IOP) | Difference between baseline IOP and IOP on each CPAP level | On completion of study visit- 3 hours | |
Secondary | Relationship between Continuous Positive Airway Pressure (CPAP) level and IOP | Correlation between level of CPAP applied and IOP | On completion of study visit - 3hours | |
Secondary | Minimum CPAP level required to increase IOP | Minimum CPAP level required to increase IOP | On completion of study visit- 3 hours | |
Secondary | Differences in change in IOP between each study group | Differences in IOP change (?IOP; IOPCPAP -IOPbaseline) at each CPAP level between the study groups | On completion of study visit - 3 hours | |
Secondary | Relationship between changes in IOP after CPAP with BMI | Correlation between IOP change (?IOP; IOPCPAP -IOPbaseline) in response to CPAP with BMI | On completion of study visit - 3 hours | |
Secondary | Relationship between changes in IOP after CPAP with lung volume (Vital Capacity-VC) | Correlation between IOP change (?IOP; IOPCPAP -IOPbaseline) in response to CPAP with Vital Capacity | On completion of study visit - 3 hours | |
Secondary | Relationship between changes in IOP after CPAP with glaucoma severity. | Correlation between IOP change (?IOP; IOPCPAP -IOPbaseline) in response to CPAP with glaucoma severity | On completion of study visit - 3 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05564091 -
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
|
N/A | |
Recruiting |
NCT02792803 -
A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma
|
Phase 4 | |
Terminated |
NCT02801617 -
Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension
|
Phase 3 | |
Completed |
NCT01384149 -
EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA
|
Phase 1 | |
Completed |
NCT00300079 -
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
|
Phase 4 | |
Enrolling by invitation |
NCT00221923 -
African Descent and Glaucoma Evaluation Study
|
||
Recruiting |
NCT05605743 -
Alternate Nostril Breathing Training in Geriatrics With Glaucoma and High Blood Pressure
|
N/A | |
Completed |
NCT04828057 -
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
|
||
Completed |
NCT01442896 -
STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk
|
||
Enrolling by invitation |
NCT05557721 -
Uddevalla Skövde Transscleral Micropulse Study
|
||
Recruiting |
NCT04595227 -
Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device
|
||
Terminated |
NCT04141865 -
Effect of Xen Implantation on the Aqueous Humor Proteome
|
||
Completed |
NCT01979913 -
An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
|
Phase 4 | |
Completed |
NCT01943721 -
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
|
Phase 1 | |
Completed |
NCT02023242 -
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
|
N/A | |
Not yet recruiting |
NCT01711177 -
Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
|
N/A | |
Completed |
NCT01769521 -
Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG
|
N/A | |
Recruiting |
NCT00773877 -
Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients
|
N/A | |
Recruiting |
NCT00773123 -
Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.
|
N/A | |
Completed |
NCT02544646 -
Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG
|
N/A |